
ESG in Life Sciences Partnerships: A Primer
A UK–China Perspective on Responsible Innovation

A UK–China Perspective on Responsible Innovation

China’s regulatory system is changing fast. Pilot zones (Hainan, Lingang, Suzhou) and NMPA reforms open doors — but only if UK innovators prepare properly. Too many underestimate the differences, losing time and credibility.

Innovation in life sciences often moves faster than the systems designed to support it. After two decades working across the UK and China, we’ve seen founders and ecosystem leaders face barriers not of ambition but of structure — from regulation and networks to pathways, trust and translation.

EFEC is laying the foundations of a UK–China Life Sciences Innovation Hub to connect innovators, investors and UK partners.